Measurement of glycine in gray and white matter in the human brain in vivo by 1H MRS at 7.0 T
- PMID: 22693073
- PMCID: PMC3396723
- DOI: 10.1002/mrm.24368
Measurement of glycine in gray and white matter in the human brain in vivo by 1H MRS at 7.0 T
Abstract
The concentration of glycine (Gly) was measured in gray matter (GM) and white matter (WM) in the human brain using single-voxel localized (1)H MRS at 7 T. A point-resolved spectroscopy sequence with echo time = 150 ms was used for measuring Gly levels in various regions of the frontal and occipital lobes in 11 healthy volunteers and one subject with a glioblastoma. The point-resolved spectroscopy spectra were analyzed with LCModel using basis functions generated from density matrix simulations that included the effects of volume localized radio-frequency and gradient pulses. The fraction of GM and white matter within the voxels was obtained from T(1)-weighted image segmentation. The metabolite concentrations within the voxels, estimated with respect to the GM + WM water concentrations, were fitted to a linear function of fractional GM content. The Gly concentrations in pure GM and white matter were estimated to be 1.1 and 0.1 mM, with 95% confidence intervals 1.0-1.2 and 0.0-0.2, respectively.
Copyright © 2012 Wiley Periodicals, Inc.
Figures




References
-
- Lynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology. 2009;56:303–309. - PubMed
-
- Eulenburg V, Armsen W, Betz H, Gomeza J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci. 2005;30:325–333. - PubMed
-
- Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glutamatergic transmission in schizophrenia. Ann N Y Acad Sci. 2003;1003:113–118. - PubMed
-
- Javitt DC. Glycine transport inhibitors and the treatment of schizophrenia. Biol Psychiatry. 2008;63:6–8. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources